279 results on '"Roobol M.J."'
Search Results
252. A0514 - Treatment free survival and the pattern of follow-up treatments after curative prostate cancer treatment, a reflection of electronic health record data.
253. A0001 - The impact of prostate cancer ADT and EBRT follow-up treatment on patient-reported quality of life – results from the EUPROMS 2.0 follow-up study.
254. A0740 - A comparison of the PLUM and RPCRC- MRI-based prostate cancer risk prediction models in two North American and European cohorts.
255. A0893 - Causal modeling to unravel the screening effect in ERSPC: Structural equation analysis of the Dutch, Finnish and Swedish data.
256. A0496 - A comprehensive overview of patient reported outcomes: Results from the PIONEER consortium.
257. A0256 - Reducing overtreatment of prostate cancer patients: Revisiting the European Association of Urology (EAU) risk group classification by using 18 years of follow-up data.
258. A1145 - Continence after introducing NeuroSAFE in radical prostatectomy.
259. A1052 - Recommendations for using Big Data in Prostate Cancer: The experience from the PIONEER Watchful Waiting Study-a-thon.
260. A0959 - Mapping EAU guideline practice variations across Europe: An audit of ADT before surgery in locally advanced and high-risk prostate cancer in 6315 cases across 31 European countries.
261. A0607 - Complications after transrectal prostate biopsy with antibiotic prophylaxis versus transperineal without antibiotic prophylaxis: Comparison of two clinical practices.
262. A0603 - Prostate cancer detection rate of transrectal versus transperineal MRI-TRUS fusion prostate biopsy: experience in 794 cases.
263. A0370 - Shifting risk-stratified early detection of prostate cancer to primary health care.
264. 949 Long-term quality of life outcomes after active surveillance or curative treatment for prostate cancer.
265. A1165 - Identification of pathologic factors associated with intraoperative positive surgical margins at NeuroSAFE for clinical decision-making on nerve-sparing surgery.
266. 654 ANXIETY IN MEN ON ACTIVE SURVEILLANCE FOR EARLY PROSTATE CANCER
267. 664 OVERALL VERSUS DISEASE-SPECIFIC SURVIVAL OF SCREEN- DETECTED PROSTATE CANCER PATIENTS WHO WERE INITIALLY MANAGED EXPECTANTLY
268. Petrochemistry of lavas from the Central Arabian shield
269. Evolution of the Bahah province — Central arabian shield
270. 547 - Prostate MRI, with or without targeted biopsy and standard biopsy for detecting prostate cancer: A Cochrane systematic review and meta-analysis.
271. 460 - Discontinuation of active surveillance of men with GG2 PCa: Assessment of 14 centres in 8 countries in the Movember GAP3 consortium.
272. PT054 - Upgrading in men with serial MRIs on active surveillance for low-risk prostate cancer: Are confirmatory biopsies still necessary?
273. PT035 - Eight year patient reported outcome data of the first 150 Dutch men on active surveillance in the Prostate cancer Research International Active Surveillance study (PRIAS).
274. PT043 - Active surveillance of men younger than 60: Assessment of differences in discontinuation and treatment choice in the Movember GAP3 Consortium.
275. 108 - International comparison in the Risk Calculator-based age-standardized incidence rate of prostate cancer between Japan and the Netherlands.
276. O-8 - Large cribriform growth pattern identifies cribriform Gleason score 3+4=7 prostate cancer patients at high risk for recurrence and metastasis.
277. 381 - A multi-centre evaluation of the role of Prostate Health Index (PHI) in regions with different prevalences of prostate cancer: A different reference range is needed for European and Asian.
278. 611 Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy.
279. 809 FALSE-NEGATIVE PROSTATE BIOPSY FOR ADENOCARCINOMA: INCIDENCE AND FOLLOW-UP IN A HIGH-RISK SCREENED POPULATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.